Articles

Prehypertension is associated with cardiovascular disease and insulin resistance. However, whether subjects with prehypertension have more diabetes risk is not known. Researchers David R. Mullican, MD, Carlos Lorenzo, MD, and Steven M. Haffner, MD, University of Texas Health Science Center San Antonio, examined whether prehypertension is a risk factor for …

The purpose of the study is to summarize evidence about the diagnostic accuracy of the 5.07/10-g monofilament test in peripheral neuropathy.

A Blacksburg, VA, medical company says it is a step closer to finding a potential cure for Type 1 diabetes, tapping pigs as a source of healthy beta-cells. So far it has been successful in monkeys for more than a year. 

Biodel, Inc., announced that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject(R) as a treatment for diabetes.

Standard therapy still recommended over steroid injections, researchers say.

Pharmacists could be the missing link in controlling blood sugars.The role of pharmacists hasn’t received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce treatment costs and improve outcomes.

Inherited genetic variations exist between whites and blacks living in the U.S., leading to less efficient metabolism of glucose and predisposition to diabetes in blacks.

A new study suggests there’s a link between having heavy sons and cardiovascular death, but having underweight sons appears to be less hazardous than expected.  

Addressing issues raised recently, to much controversy and debate, a prospective observational study in Type 2 diabetes patients suggests that aggressive control of glycated hemoglobin (HbA1c) levels — that is, to no higher than 6.5% or 7% — significantly improves cardiovascular risk over five years, but only in patients who …

Older adults who used the herbal supplement Ginkgo biloba for several years did not have a slower rate of cognitive decline compared to adults who received placebo, according to a new study.